Board of Directors

 
The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Karen Arts

Karen Arts

Co-founder

Executive Director Canadian Cancer Clinical Trials Network (3CTN)
Jim Pankovich

Jim Pankovich

Chair

Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Rachel Syme

Rachel Syme

Vice Chair

Assistant Director, Institute of Cancer Research, CIHR
Patrick Clifford

Patrick Clifford

Treasurer

N2 Board Member

N2 Treasurer

Erin Cherban

Erin Cherban

Secretary

Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)

 

Linda Bennett

Linda Bennett

Board Member

Project Manager, Marvelle Koffler Breast Centre Research Program
Kathy Brodeur-Robb

Kathy Brodeur-Robb

Board Member

Executive Director C-17 Council
Lisa Johnston

Lisa Johnston

Board Member

Clinical Research Facilitator, Ottawa Hospital Research Institute (OHRI)

Tammy Mah-Fraser

Tammy Mah-Fraser

Board Member

Director, Platform Operations – Alberta Innovates – Health Solutions
Janette Panhuis

Janette Panhuis

Board Member

Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University